专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

71. 发明授权

US07111024B2 Document management system for automating operations performed on documents in data storage areas 有权
公开(公告)号：US07111024B2
公开(公告)日：2006-09-19
申请号：US10269648
申请日：2002-10-10
申请人： George Koppich , Michael Yeung , Louis Ormond , Harpreet Singh
发明人： George Koppich , Michael Yeung , Louis Ormond , Harpreet Singh
IPC分类号： G06F17/30
CPC分类号： G06F17/30011 , Y10S707/99943 , Y10S707/99954
摘要： This invention is related to document management systems, and more particularly, to a document management system for automating selected operations to be performed on at least one document in a data storage area. The invention is directed to a method and system for automatically performing preselected operations on electronic documents. The method and system comprising the steps of and means adapted for receiving at least one electronic document into a data storage area accessible by a plurality of users; associating at least one preselected operation with the data storage area, such that such preselected operation is performed automatically by any document received into the data storage area; and performing the preselected operation on each electronic document received into the data storage area.

72. 发明申请

US20060019096A1 Field-responsive superparamagnetic composite nanofibers and methods of use thereof 审中-公开
标题翻译：场响应超顺磁复合纳米纤维及其使用方法
公开(公告)号：US20060019096A1
公开(公告)日：2006-01-26
申请号：US11141205
申请日：2005-06-01
申请人： T. Hatton , Gregory Rutledge , Harpreet Singh , Mao Wang
发明人： T. Hatton , Gregory Rutledge , Harpreet Singh , Mao Wang
IPC分类号： D02G3/00
CPC分类号： D01D5/0038 , D01D5/0007 , D01F1/10 , D01F6/14 , D01F6/16 , Y10T428/2913
摘要： The present invention relates to magnetic field-responsive fibers, which comprise magnetite particles and a polymeric matrix. The invention also provides methods of producing the same, in particular via electrospinning of a stably dispersed or monodispersed polymer solution, either aqueous or organic, comprising the magnetite particles, and applications thereof.
摘要翻译：本发明涉及包含磁铁矿颗粒和聚合物基体的磁场响应纤维。本发明还提供了制备该方法的方法，特别是通过静电纺丝稳定分散或单分散的包含磁铁矿颗粒的水性或有机聚合物溶液及其应用。

73. 发明申请

US20170262824A1 Currency Exchange System and Methodology 审中-公开
公开(公告)号：US20170262824A1
公开(公告)日：2017-09-14
申请号：US15455500
申请日：2017-03-10
申请人： Harpreet Singh
发明人： Harpreet Singh
IPC分类号： G06Q20/10 , G06Q20/32
CPC分类号： G06Q20/1085 , G06Q20/3223 , G06Q20/3278 , G06Q20/381
摘要： A method and system facilitating the dispensing of foreign currency from a foreign ATM comprising a smartphone enabled mobile app controlling and enabling the method, a foreign currency account created and controlled through the mobile app, the foreign currency account maintained by a financial institution participating in the international monetary exchange system, funds in the foreign currency app created by exchanging a home currency for a foreign currency, the mobile app able to communicate with the foreign ATM to provide secure identification and withdrawal information, the entity operating the foreign ATM able to communicate with the financial entity maintaining the foreign currency account, which is able to transfer funds to the foreign ATM operating entity to repay the foreign operating entity for foreign currency dispensed from the foreign ATM.

74. 发明授权

US09175040B2 Immunotherapeutic peptides against neuronal and brain tumors and related methods and compositions 有权
标题翻译：针对神经元和脑肿瘤的免疫治疗肽及相关方法和组合物
公开(公告)号：US09175040B2
公开(公告)日：2015-11-03
申请号：US12180170
申请日：2008-07-25
申请人： Toni Weinschenk , Oliver Schoor , Claudia Trautwein , Norbert Hilf , Steffen Walter , Harpreet Singh
发明人： Toni Weinschenk , Oliver Schoor , Claudia Trautwein , Norbert Hilf , Steffen Walter , Harpreet Singh
IPC分类号： C07K7/08 , C07K7/06 , A61K38/00
CPC分类号： A61K35/17 , A61K38/00 , C07K7/06 , C07K7/08 , C07K14/4748 , C12N5/0638
摘要： The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 11 novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
摘要翻译：本发明涉及用于免疫治疗方法的肽，核酸和细胞。特别地，本发明涉及癌症的免疫治疗。本发明还涉及肿瘤相关的细胞毒性T细胞（CTL）肽表位，其单独或与作为刺激抗肿瘤免疫应答的疫苗组合物的活性药物成分的其它肿瘤相关肽的组合。本发明涉及可用于引发抗肿瘤免疫应答的疫苗组合物中的11种新型肽序列及其衍生自人类肿瘤细胞的HLA I类和II类分子的变体。

75. 发明授权

US09132177B2 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers 有权
标题翻译：用于治疗胃癌和其他癌症的肿瘤相关肽和相关抗癌疫苗的组成
公开(公告)号：US09132177B2
公开(公告)日：2015-09-15
申请号：US13051568
申请日：2011-03-18
申请人： Jens Fritsche , Toni Weinschenk , Steffen Walter , Peter Lewandrowski , Harpreet Singh
发明人： Jens Fritsche , Toni Weinschenk , Steffen Walter , Peter Lewandrowski , Harpreet Singh
IPC分类号： A61K38/04 , A61K39/39 , C07K7/00 , A61K39/00 , C07K14/47
CPC分类号： A61K39/0011 , A61K2039/55511 , A61K2039/55522 , C07K14/4748
摘要： The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gastric cancers (GC).
摘要翻译：本发明涉及免疫治疗肽及其在免疫治疗中的用途，特别是癌症的免疫治疗。本发明公开了肿瘤相关的T辅助细胞肽表位，其单独或与作为刺激抗肿瘤免疫应答的疫苗组合物的活性药物成分的其它肿瘤相关肽组合。特别地，本发明的肽的组合物可用于引发针对胃癌（GC）的抗肿瘤免疫应答的疫苗组合物中。

76. 发明授权

US09056069B2 Cancer therapy based on tumor associated antigens derived from cyclin D1 有权
标题翻译：基于衍生自细胞周期蛋白D1的肿瘤相关抗原的癌症治疗
公开(公告)号：US09056069B2
公开(公告)日：2015-06-16
申请号：US13150785
申请日：2011-06-01
申请人： Harpreet Singh , Toni Weinschenk , Steffen Walter
发明人： Harpreet Singh , Toni Weinschenk , Steffen Walter
IPC分类号： A61K39/00 , A61K38/20 , A61K38/21 , A61K45/06 , C07K14/47 , A61K31/404 , A61K31/44 , A61K31/675 , A61K39/39 , C12N5/0783 , A61K38/17 , A61K38/19
CPC分类号： A61K39/0011 , A61K31/404 , A61K31/44 , A61K31/675 , A61K38/1709 , A61K38/193 , A61K38/20 , A61K38/2013 , A61K38/2026 , A61K38/21 , A61K39/39 , A61K45/06 , C07K14/4738 , C12N5/0638 , G01N2800/24 , G01N2800/7028 , A61K2300/00
摘要： The present invention relates to cyclin D1-derived peptides for use in the improved treatment of cancer in a patient, particularly in the form of a combination therapy using a vaccine. Other aspects relate to the use of the peptides or a combination thereof as a diagnostic tool.
摘要翻译：本发明涉及用于改善患者癌症治疗的细胞周期蛋白D1衍生肽，特别是以使用疫苗的组合疗法的形式。其他方面涉及肽或其组合的用途作为诊断工具。

77. 发明授权

US08653035B2 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers 有权
公开(公告)号：US08653035B2
公开(公告)日：2014-02-18
申请号：US13588206
申请日：2012-08-17
申请人： Toni Weinschenk , Oliver Schoor , Claudia Trautwein , Norbert Hilf , Steffan Walter , Harpreet Singh
发明人： Toni Weinschenk , Oliver Schoor , Claudia Trautwein , Norbert Hilf , Steffan Walter , Harpreet Singh
IPC分类号： A61K38/00
CPC分类号： C07K7/06 , A61K35/17 , A61K38/00 , A61K39/0011 , A61K2039/5154 , A61K2039/5158 , A61K2039/53 , A61K2039/55511 , A61K2039/55516 , A61K2039/55522 , A61K2039/55561 , A61K2039/55588 , A61K2039/572 , A61K2039/605 , A61K2039/6081 , A61K2039/6093 , A61M5/002 , C07K7/08 , C07K14/70539 , C07K2319/00 , C07K2319/40 , C12N5/0638 , C12N2501/50 , G01N33/57492 , Y02A50/472
摘要： The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gliomas.

78. 发明申请

US20130045191A1 NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER 审中-公开
公开(公告)号：US20130045191A1
公开(公告)日：2013-02-21
申请号：US13635896
申请日：2011-03-15
申请人： Toni Weinschenk , Jens Fritsche , Steffen Walter , Peter Lewandrowski , Harpreet Singh
发明人： Toni Weinschenk , Jens Fritsche , Steffen Walter , Peter Lewandrowski , Harpreet Singh
IPC分类号： A61K35/26 , C07K7/08 , C07K14/725 , C12N5/0783 , A61P37/04 , A61P35/00 , C12N5/10 , C12P21/02 , C07K7/06 , C12N15/12
CPC分类号： A61K38/1709 , A61K39/0011 , A61K2039/5158 , A61K2039/572 , A61K2039/585 , A61P35/00 , C07K7/06 , C07K2319/00 , G01N33/505
摘要： The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 95 novel peptide sequences and their variants derived from HLA class I molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.

79. 发明授权

US07674920B2 Methods for preparing oxydiphthalic anhydrides, oxydiphthalic anhydrides prepared thereby, and polyetherimides derived therefrom 有权
标题翻译：制备氧联二邻苯二甲酸酐的方法，由此制备的氧联二邻苯二甲酸酐和由其衍生的聚醚酰亚胺
公开(公告)号：US07674920B2
公开(公告)日：2010-03-09
申请号：US12058331
申请日：2008-03-28
申请人： Beatriz Penalver Bernabe , Lioba Maria Kloppenburg , Matt Kuhlman , Roy Ray Odle , Eric Pressman , Narayan Ramesh , Harpreet Singh
发明人： Beatriz Penalver Bernabe , Lioba Maria Kloppenburg , Matt Kuhlman , Roy Ray Odle , Eric Pressman , Narayan Ramesh , Harpreet Singh
IPC分类号： C07D307/89
CPC分类号： C07D307/88 , C07D307/89 , C08G73/1046
摘要： A method for preparing an oxydiphthalic anhydride comprises contacting, under reactive and substantially anhydrous conditions in a reactor, at least one halophthalic anhydride containing more than 250 ppm chlorophthalide impurity with a carbonate of the formula M2CO3, wherein M is an alkali metal, in the presence of a catalytic proportion of at least one phase transfer catalyst selected from the group consisting of hexaalkylguanidinium halides and alpha,omega-bis(pentaalkylguanidinium)alkane salts, phosphonium salts, phosphazenium salts, pyridinium salts, phosphazenium salts, ammonium salts, and combinations thereof. The phase transfer catalyst is present in a sufficient amount to prepare the oxydiphthalic anhydride when the chlorophthalide is present in an amount that is more than 250 ppm, and the oxydiphthalic anhydride is produced in a yield, based on the carbonate, of at least 70%.
摘要翻译：一种制备氧联二邻苯二甲酸酐的方法包括在反应器和反应性基本上无水的条件下，在反应器中使至少一种含有多于250ppm氯酞酸盐杂质的卤代邻苯二甲酸酐与式M2CO3的碳酸酯（其中M为碱金属）在存在下选自六烷基卤化镓和α，ω-双（五烷基胍）烷烃盐，鏻盐，磷氮烯基鏻盐，吡啶鎓盐，磷氮烯基鏻盐，铵盐及其组合的至少一种相转移催化剂的催化剂比例。当氯代苯酞以250ppm以上的量存在时，相转移催化剂的存在量足以制备氧联二邻苯二甲酸酐，并且基于碳酸酯的产率以氧化邻苯二甲酸酐的产率为至少70％。

80. 发明授权

US07652783B2 System and method for holding and deleting requests in a job queue 失效
标题翻译：在作业队列中保存和删除请求的系统和方法
公开(公告)号：US07652783B2
公开(公告)日：2010-01-26
申请号：US11281550
申请日：2005-11-17
申请人： Marianne Kodimer , Harpreet Singh , Mustafa Seifi , Ken Stephenson
发明人： Marianne Kodimer , Harpreet Singh , Mustafa Seifi , Ken Stephenson
IPC分类号： G06K15/00
CPC分类号： G06Q10/10
摘要： This invention is directed to a document processing system and method. The method begins with a user logging onto a document processing system, inputs identification data, and selects one or more documents for document processing by the document processing system. The selected document is then uploaded to the document processing system, which renders the document to determine the number of pages and other document relevant information. The user then selects one of the available service locations. The cost associated with the requested document processing operation is then calculated and displayed to the user, along with available payment options. Once the user has selected the desired payment method, the document, with selected options and preferences, is transmitted to the selected service location for output on a document processing device thereon. The received request is stored in queue until such time as the user releases the request for further processing. When the request is resident in the queue for greater than a predetermined time, it is deleted automatically. To release the queued document for further processing, the user is required to log onto the document processing device, select the document from a list corresponding to the user, and verify payment. The requested document processing operation is then performed.
摘要翻译：本发明涉及一种文件处理系统和方法。该方法开始于用户登录到文档处理系统，输入标识数据，并且由文档处理系统选择用于文档处理的一个或多个文档。所选择的文档然后被上传到文档处理系统，这使文档确定页数和其他文档相关信息。然后，用户选择可用服务位置之一。然后计算与请求的文档处理操作相关联的成本，并显示给用户以及可用的支付选项。一旦用户选择了所需的支付方式，具有所选择的选项和偏好的文档被发送到所选择的服务位置，以在其上的文档处理设备上输出。接收的请求被存储在队列中，直到用户释放进一步处理的请求为止。当请求驻留在队列中超过预定时间时，它将被自动删除。要释放排队的文档进一步处理，用户需要登录到文档处理设备，从与用户相对应的列表中选择文档，并验证付款。然后执行所请求的文档处理操作。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式